Arcus Biosciences, Inc.
RCUSFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Arcus Biosciences, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 10 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| UBS Group AG | 2026-03-31 | 288,857 | $6.24M | SEC filing |
| LPL Financial LLC | 2026-03-31 | 22,860 | $494K | SEC filing |
| IFP Advisors, Inc | 2026-03-31 | 18 | $389 | SEC filing |
| MARSHALL WACE, LLP | 2026-03-31 | 3,761,437 | $81.2M | SEC filing |
| State of Alaska, Department of Revenue | 2026-03-31 | 41,865 | Not shown | SEC filing |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 2026-03-31 | 20,963 | $453K | SEC filing |
| Root Financial Partners, LLC | 2026-03-31 | 40 | $864 | SEC filing |
| Connor, Clark & Lunn Investment Management Ltd. | 2026-03-31 | 281,681 | $6.08M | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 107,979 | $2.33M | SEC filing |
| JANUS HENDERSON GROUP PLC | 2026-03-31 | 42,338 | $916K | SEC filing |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2026-03-31 | 134,217 | $2.9M | SEC filing |
| SMA Capital LLC | 2026-03-31 | 258 | $5.57K | SEC filing |
| RAYMOND JAMES FINANCIAL INC | 2026-03-31 | 37,766 | $816K | SEC filing |
| SummitTX Capital, L.P. | 2026-03-31 | 34,219 | $739K | SEC filing |
| CANTOR FITZGERALD, L. P. | 2026-03-31 | 45,000 | $972K | SEC filing |
| Russell Investments Group, Ltd. | 2026-03-31 | 80,833 | $1.75M | SEC filing |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | 2026-03-31 | 20,950 | Not shown | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 424,700 | $9.17M | SEC filing |
| PRINCIPAL FINANCIAL GROUP INC | 2026-03-31 | 413,778 | $8.94M | SEC filing |
| Birchview Capital, LP | 2026-03-31 | 25,889 | $559K | SEC filing |
- Each value is checked against Arcus Biosciences, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Arcus Biosciences, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Arcus Biosciences, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-01-05 · Jaen Juan C.: Larger than 72 of the 79 other insider sales of Common Stock on file. SEC filing
- 2025-12-04 · Jaen Juan C.: Larger than all 79 other insider sales of Common Stock on file. SEC filing
- 2025-11-17 · Jaen Juan C.: Larger than 74 of the 79 other insider sales of Common Stock on file. SEC filing
- 2025-11-07 · Jarrett Jennifer: Larger than 78 of the 79 other insider sales of Common Stock on file. SEC filing
- 2025-10-29 · Jaen Juan C.: Larger than 77 of the 79 other insider sales of Common Stock on file. SEC filing
- 2025-10-08 · Jarrett Jennifer: Larger than 75 of the 79 other insider sales of Common Stock on file. SEC filing
- 2024-02-27 · Jarrett Jennifer: Larger than 73 of the 79 other insider sales of Common Stock on file. SEC filing
- 2023-07-28 · Jarrett Jennifer: Larger than 76 of the 79 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-24 | Jaen Juan C. · President | Common Stock | S — Open market or private sale | −6,431 | 29.66 | SEC filing |
| 2026-06-23 | Jaen Juan C. · President | Common Stock | S — Open market or private sale | −14,067 | 27.69 | SEC filing |
| 2026-06-23 | Jaen Juan C. · President | Common Stock | S — Open market or private sale | −1,697 | 28.06 | SEC filing |
| 2026-06-22 | Jaen Juan C. · President | Common Stock | S — Open market or private sale | −9,236 | 27.03 | SEC filing |
| 2026-06-01 | Azoy Alexander · Chief Accounting Officer | Common Stock | S — Open market or private sale | −2,562 | 25.77 | SEC filing |
| 2026-05-11 | Goeltz II Robert C. · Chief Financial Officer | Common Stock | S — Open market or private sale | −7,763 | 25.63 | SEC filing |
| 2026-01-05 | Jaen Juan C. · President | Common Stock | S — Open market or private sale | −2,053 | 22.34 | SEC filing |
| 2026-01-05 | Jaen Juan C. · President | Common Stock | S — Open market or private sale | −100 | 23.20 | SEC filing |
Showing 8 of 15 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-11 | Tang Carolyn C. · General Counsel | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −34,090 | SEC filing |
| 2026-06-11 | Tang Carolyn C. · General Counsel | Common Stock | M — Exercise or conversion of derivative security | +34,090 | SEC filing |
| 2026-06-11 | PERLMAN ANDREW J · Director | Common Stock | A — Grant, award, or other acquisition | +5,700 | SEC filing |
| 2026-06-11 | Ribas Antoni · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +16,900 | SEC filing |
| 2026-06-11 | Lambert Nicole · Director | Common Stock | A — Grant, award, or other acquisition | +5,700 | SEC filing |
| 2026-06-11 | Lacey David L. · Director | Common Stock | A — Grant, award, or other acquisition | +5,700 | SEC filing |
| 2026-06-11 | KANEKO YASUNORI · Director | Common Stock | A — Grant, award, or other acquisition | +5,700 | SEC filing |
| 2026-06-11 | Machado Patrick · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +16,900 | SEC filing |
Showing 8 of 35 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-12-19 | Azoy Alexander · Chief Accounting Officer | Common Stock | D — Disposition to the issuer | −3,007 | SEC filing |
| 2023-12-29 | ROSEN TERRY J · Chief Executive Officer | Common Stock | W — Acquisition or disposition by will or laws of descent | +448 | SEC filing |
| 2023-12-20 | Azoy Alexander · Chief Accounting Officer | Common Stock | D — Disposition to the issuer | −68 | SEC filing |
| 2023-12-19 | ROSEN TERRY J · Chief Executive Officer | Common Stock | D — Disposition to the issuer | −14,000 | SEC filing |
| 2023-12-19 | Jaen Juan C. · President | Common Stock | D — Disposition to the issuer | −6,259 | SEC filing |
| 2023-12-19 | Azoy Alexander · Chief Accounting Officer | Common Stock | D — Disposition to the issuer | −661 | SEC filing |
| 2023-12-19 | Tang Carolyn C. · General Counsel | Common Stock | D — Disposition to the issuer | −4,076 | SEC filing |
| 2023-12-19 | Jarrett Jennifer · Chief Operating Officer | Common Stock | D — Disposition to the issuer | −11,492 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.